BREAST CANCER THERAPY USING AN ENGINEERED RESPIRATORY SYNCYTIAL VIRUS
摘要
<p>The invention discloses an engineered oncolytic respiratory syncytial virus (RSV), NS1 gene deficient RSV, and its usage to treat lung cancer by killing cancer cells with in vitro and in vivo evidences.</p>
